Skip to main content
. 2022 Oct 19;36(15):F17–F26. doi: 10.1097/QAD.0000000000003405

Table 1.

Participant characteristics by case status among people with HIV tested for SARS-CoV-2 infection between December 14, 2020 and November 21, 2021, Ontario, Canada.

Test-positive cases Test-negative controls
N % N % SD
Total 801 100.0 8879 100.0
Number of COVID-19 vaccine doses (at time of test)
 0 640 79.9 4635 52.2 0.61
 1 105 13.1 1409 15.9 0.08
 2 56 7.0 2835 31.9 0.66
Age group (years)
 19–29 74 9.2 656 7.4 0.07
 30–39 193 24.1 1699 19.1 0.12
 40–49 206 25.7 2036 22.9 0.07
 50–59 217 27.1 2640 29.7 0.06
 ≥60 111 13.9 1848 20.8 0.18
Sex
 Male 586 73.2 6656 75.0 0.04
 Female 215 26.8 2223 25.0 0.04
Year-month of specimen collection
 2020-12 63 7.9 624 7.0 0.03
 2021-01 127 15.9 1036 11.7 0.12
 2021-02 72 9.0 892 10.0 0.04
 2021-03 119 14.9 1097 12.4 0.07
 2021-04 196 24.5 966 10.9 0.36
 2021-05 108 13.5 789 8.9 0.15
 2021-06 23 2.9 568 6.4 0.17
 2021-07 10 1.2 577 6.5 0.27
 2021-08 28 3.5 633 7.1 0.16
 2021-09 21 2.6 643 7.2 0.21
 2021-10 22 2.7 650 7.3 0.21
 2021-11 12 1.5 404 4.6 0.18
Pandemic wave
 Wave 2: Dec. 14, 2020 to March 6, 2021 284 35.5 2799 31.5 0.08
 Wave 3: March 7, 2021 to June 26, 2021 423 52.8 3099 34.9 0.37
 Wave 4: June 27, 2021 to November 21, 2021 94 11.7 2981 33.6 0.54
Public health region
 Toronto 446 55.7 4457 50.2 0.11
 Central East 7 0.9 295 3.3 0.17
 Central West 99 12.4 1190 13.4 0.03
 Durham 23 2.9 231 2.6 0.02
 Eastern 11 1.4 288 3.2 0.12
 Northern 23 2.9 354 4.0 0.06
 Ottawa 45 5.6 663 7.5 0.07
 Peel 72 9.0 449 5.1 0.15
 South West 44 5.5 698 7.9 0.09
 York 31 3.9 254 2.9 0.06
Number of tests in 3 months before December 14, 2020
 0 600 74.9 5995 67.5 0.16
 1 132 16.5 1697 19.1 0.07
 2+ 69 8.6 1187 13.4 0.15
Receipt of 2019/20 or 2020/21 flu vaccine
 Neither season 471 58.8 4630 52.1 0.13
 Either season 181 22.6 2310 26.0 0.08
 Both seasons 149 18.6 1939 21.8 0.08
Number of comorbidities
 0 442 55.2 4191 47.2 0.16
 1 221 27.6 2566 28.9 0.03
 2+ 138 17.2 2122 23.9 0.17
Comorbidities
 Chronic respiratory disease 155 19.4 2338 26.3 0.17
 Hypertension 151 18.9 2085 23.5 0.11
 Diabetes 103 12.9 1173 13.2 0.01
 Frailty/dementia 73 9.1 838 9.4 0.01
 Chronic heart disease 53 6.6 780 8.8 0.08
 Chronic kidney disease/dialysis 54 6.7 622 7.0 0.01
 Advanced liver disease 34 4.2 374 4.2 0.00
 Autoimmune disorders 24 3.0 426 4.8 0.09
 History of stroke/TIA 13 1.6 162 1.8 0.02
Neighborhood-level essential workers quintile
 1 (0–32.5%) 193 24.1 2921 32.9 0.20
 2 (32.5–42.3%) 134 16.7 1586 17.9 0.03
 3 (42.3–49.8%) 143 17.9 1439 16.2 0.04
 4 (50.0–57.5%) 163 20.3 1480 16.7 0.09
 5 (57.5–100%) 168 21.0 1453 16.4 0.12
Neighborhood-level average number of persons per dwelling quintile
 1 (0–2.1) 314 39.2 4046 45.6 0.13
 2 (2.2–2.4) 119 14.9 1492 16.8 0.05
 3 (2.5–2.6) 87 10.9 861 9.7 0.04
 4 (2.7–3.0) 133 16.6 1415 15.9 0.02
 5 (3.1–5.7) 148 18.5 1065 12.0 0.18
Neighborhood-level proportion of persons self-identifying as visible minority quintile
 1 (0.0–2.2%) 26 3.2 687 7.7 0.20
 2 (2.2–7.5%) 49 6.1 849 9.6 0.13
 3 (7.5–18.7%) 125 15.6 1532 17.3 0.04
 4 (18.7–43.5%) 236 29.5 2886 32.5 0.07
 5 (43.5–100%) 365 45.6 2925 32.9 0.26
Neighborhood-level median income quintile
 1 (lowest) 359 44.8 3161 35.6 0.19
 2 166 20.7 1885 21.2 0.01
 3 123 15.4 1582 17.8 0.07
 4 90 11.2 1087 12.2 0.03
 5 (highest) 63 7.9 1164 13.1 0.17

COVID-19, coronavirus disease 2019; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; SD, standardized difference.